Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bruder: On the Edge of Autoimmunity. (0.11 sec) 

On the Edge of Autoimmunity

- shouxi.net
D Bruder, AM Westendorf, W Hansen, S … - Diabetes, 2005 - Am Diabetes Assoc
Targeting of antigens to immature dendritic cells has been shown to result in
antigen-specific T-cell tolerance in vivo. In the INS-HA/TCR-HA transgenic mouse
model for type 1 diabetes, we tested the potential of the dendritic cell– ...
Cited by 33 - Related articles - BL Direct - All 7 versions

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine …

- hematologylibrary.org
I Caminschi, AI Proietto, F Ahmet, S … - Blood, 2008 - bloodjournal.hematologylibrary.org
A novel dendritic cell (DC)–restricted molecule, Clec9A, was identified by
gene expression profiling of mouse DC subtypes. Based on sequence similarity, a
human ortholog was identified. Clec9A encodes a type II membrane protein ...
Cited by 15 - Related articles - All 5 versions

Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice

- aacrjournals.org
K Mahnke, Y Qian, S Fondel, J Brueck, C … - Cancer Research, 2005 - AACR
Anti ( )-DEC-205 antibodies target to the DEC-205 receptor that mediates antigen
presentation to T cells by dendritic cells. To exploit these properties for
immunization purposes, we conjugated the melanoma antigen ...
Cited by 35 - Related articles - BL Direct - All 4 versions

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin


D Sancho, D Mourão-Sá, OP Joffre, O Schulz … - The Journal of clinical investigation, 2008 - pubmedcentral.nih.gov
The mouse CD8α + DC subset excels at cross-presentation of antigen, which can
elicit robust CTL responses. A receptor allowing specific antigen targeting to
this subset and its equivalent in humans would therefore be useful for the ...
Cited by 20 - Related articles - BL Direct - All 22 versions

Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 …

- jimmunol.org
E Tagliani, P Guermonprez, J Sepulveda, M … - The Journal of Immunology, 2008 - Am Assoc Immnol
Improvement of the strategy to target tumor Ags to dendritic cells (DCs) for
immunotherapy requires the identification of the most appropriate
ligand/receptor pairing. We screened a library of Ab fragments on mouse DCs ...
Cited by 7 - Related articles - All 5 versions

Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance …

- nih.gov
A Mukhopadhaya, T Hanafusa, I Jarchum, YG … - Proceedings of the National Academy of Sciences, 2008 - National Acad Sciences
Type 1 diabetes (T1D) is an autoimmune disease resulting from defects in central
and peripheral tolerance and characterized by T cell-mediated destruction of
islet β cells. Cytotoxic CD8 + T cells, reactive to β cell antigens, are ...
Cited by 8 - Related articles - BL Direct - All 7 versions

CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic …

- nih.gov
C Huysamen, JA Willment, KM Dennehy, GD … - Journal of Biological Chemistry, 2008 - ASBMB
We describe here the first characterization of CLEC9A, a group V C-type
lectin-like receptor located in the “Dectin-1 cluster” of related receptors,
which are encoded within the natural killer (NK)-gene complex. Expression ...
Cited by 13 - Related articles - All 8 versions

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell …


FVV Castro, AL Tutt, AL White, JL Teeling, S … - European Journal of Immunology, 2008 - interscience.wiley.com
The magnitude and quality of T cell responses generated when Ag is targeted to
receptors on DC is influenced by both the specific receptor targeted and its
distribution among DC subsets. Here we examine the targeting of the model ...
Cited by 14 - Related articles - All 3 versions

[CITATION] Immunotherapy of type 1 diabetes mellitus


L Chatenoud, 2000 - content.karger.com
Type 1 diabetes mellitus (T1D) is a T-cell-mediated autoimmune disease [1, 2].
It is thus logical to modulate the immune system to stop the progression of the
disease as it is widely done for other autoimmune diseases. T1D presents, ...
Cited by 3 - Related articles - All 4 versions

[CITATION] Devising murine models to better adapt clinical protocols: sequential low-dose treatment …


HH Campos, JF Bach, L Chatenoud - Transplantation proceedings, 1993 - cat.inist.fr
Devising murine models to better adapt clinical protocols: sequential low-dose
treatment with anti-CD 3 and anti-CD 4 monoclonal antibodies to prevent fully ...
Cited by 5 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google